S&P 500 7,591.70 −0.58%
Nasdaq 26,081.73 −0.65%
S&P/TSX 35,506.28 −1.11%
Apple 326.57 +3.56%
Nvidia 218.36 −2.37%
Microsoft 492.44 +0.16%
Shopify 175.14 +0.01%
Royal Bank 284.98 −0.21%
CAD/USD 0.7225 −0.26%
CLOSED · 02:10 ET
Market ClerkRecap
Fri Sep 11 · markets closed4 signals on Sep 10223 insider buys this week · $359.5MCIRO short report next: Sep 14The week ahead

DARE

Dare Bioscience, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
0.70
−0.01 −1.67%
USD · close Sep 10

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $10.8MP/E DIV YIELD FCF YIELD -109.06%REV TTM $1.4M −7816.7%NET INCOME −$11MNET CASH $12.6M52W 0.70 – 3.27SEC XBRL · TTM TO Invalid Date

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose DARE in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on DARE in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch DARE. Know when insiders buy.
One email the day a filing lands. Free.